Acta Crystallographica Section E: Structure Reports Online.
Vol. 68.
2012.
P. o2848-o2849
Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation
We studied the expression of peroxiredoxin genes (PRDX1, PRDX2, PRDX3, and PRDX6) in human erythroleukemia K652, human breast carcinoma MCF-7, and human ovarian carcinoma SKOV-3 cells during cisplatin resistance development. It was found that drug resistance formation was accompanied by a significant increase in the expression of PRDX1, PRDX2, PRDX3, PRDX6 genes in all cancer cell strains, which confirms the important contribution of redox-dependent mechanisms into the development of cisplatin resistance of cancer cells. © 2012 Springer Science+Business Media New York.
Authors
Kalinina E.V.
1
,
Berezov T.T.
1
,
Shtil A.A.2
,
Chernov N.N.
1
,
Glazunova V.A.2
,
Novichkova M.D.
1
,
Nurmuradov N.K.
1
Publisher
New York Consultants BureauSpringer / Автономная некоммерческая организация Издательство Российской академии медицинских наук
Number of issue
6
Language
English
Pages
879-882
Status
Published
Link
Volume
153
Year
2012
Organizations
- 1 Peoples’ Friendship University of Russia
- 2 N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russian Federation
Keywords
Cisplatin; Drug resistance of tumor cells; Gene expression; Peroxiredoxin
Date of creation
19.10.2018
Date of change
27.04.2023
Share
Other records
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics).
Vol. 7469 LNCS.
2012.
P. 440-452